Drug Information

Drug General Information
Drug ID
D0BM6S
Former ID
DCL000547
Drug Name
IPI-493
Drug Type
Small molecular drug
Indication Gastric cancer [ICD9: 151; ICD10:C16] Discontinued in Phase 1 [548581]
Company
AstraZeneca
Structure
Download
2D MOL

3D MOL
Formula
C28H39N3O8
Canonical SMILES
CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)N)<br />C)OC)OC(=O)N)C)C)O)OC
InChI
1S/C28H39N3O8/c1-14-10-18-23(29)20(32)13-19(25(18)34)31-27(35)15(2)8-7-9-21(37-5)26(39-28(30)36)17(4)12-16(3)24(33)22(11-14)38-6/h7-9,12-14,16,21-22,24,26,33H,10-11,29H2,1-6H3,(H2,30,36)(H,31,35)/b9-7-,15-8+,17-12+/t14-,16-,21-,22-,24+,26-/m1/s1
InChIKey
XYFFWTYOFPSZRM-NBTLBREFSA-N
PubChem Compound ID
5351275
PubChem Substance ID
613838, 8137257, 57361352, 75344643, 113904092
Target and Pathway
Target(s) Heat shock protein HSP90 Target Info Inhibitor [550288], [550524]
References
Ref 548581Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026781)
Ref 550288Clinical pipeline report, company report or official report of AstraZeneca (2009).
Ref 550524National Cancer Institute. NCI Drug Dictionary. 2009 (CdrID=610131)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.